Jan De Witte - 01 Nov 2024 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role: President & CEO, Director
Signature: /s/ Eric Schwartz; Attorney-in-Fact
Issuer symbol: IART
Transactions as of: 01 Nov 2024
Net transactions value: -$82,171
Form type: 4
Filing time: 04 Nov 2024, 16:33:14 UTC
Previous filing: 22 May 2024
Next filing: 14 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IART	Common Stock	Options Exercise	$0	+9,814	+53%	$0.000000	28,164	01 Nov 2024	Direct	F1
transaction	IART	Common Stock	Tax liability	$82,171	-4,262	-15%	$19.28	23,902	01 Nov 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IART	Restricted Stock Units	Options Exercise	$0	-9,814	-7.5%	$0.000000	120,466	01 Nov 2024	Common Stock	9,814	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On November 1, 2022, the reporting person was granted a restricted stock unit award which vests in three equal annual installments on the first, second and third anniversaries of the grant date of 11/01/2022 and which convert into shares of common stock on a one-for-one basis. The second installment vested on 11/1/2024.